Skip to main content Skip to main navigation menu Skip to site footer
DTI logo
  • About
    • About the Journal
    • The Publisher
    • Publication ethics
    • Abstracting and indexing
    • Copyright and Licensing
    • Privacy Statement
    • Contact
  • Editorial team
  • Policies
    • Open Access policy
    • Editorial policies
    • Self archiving and sharing policy
    • Commercial policies
    • Waiver and discount policy
    • Privacy policy
  • Guidelines
    • Guidelines for Authors
    • Guidelines for Reviewers
    • Artwork guidelines
    • Publication fees
    • Content type
  • Archives
  • Latest articles
  • Open call for papers
Search
  • Register
  • Login
  • Submit now
  1. Home /
  2. Archives /
  3. Vol. 10 No. Suppl. 1 (2016): Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis /
  4. Editorial

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis

Authors

  •      

DOI:

https://doi.org/10.33393/dti.2016.1424

Abstract

No Abstract

Downloads

  • PDF

How to Cite

 , . (2016). Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis. Drug Target Insights, 10(Suppl. 1). https://doi.org/10.33393/dti.2016.1424
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 10 No. Suppl. 1 (2016): Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis

Section

Editorial

Metrics

Statistics

  • Abstract views - 1951 times
  • PDF downloads - 893 times

Sign up

Browse

  • Sections
    • Alternative Model Organisms
    • Antimicrobial Resistance
    • Phytotherapeutics and natural products
    • Miscellaneous

banners150

SCImago Journal & Country Rank

 

Completed peer reviews since:
June 5, 2020

Most read in the last 30 days
  • The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields
    1169
  • P-glycoprotein Inhibition for Optimal Drug Delivery
    364
  • Management of urinary tract infections in the era of antimicrobial resistance
    317
  • Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: A meta-analysis report in Ethiopia
    295
  • In vitro and molecular docking evaluation of apigenin-7-O-glucuronide from Psorospermum febrifugum as anti-inflammatory and predicted antiplasmodial compound
    259

Drug Target Insights | eISSN 1177-3928

© AboutScience Srl  | www.aboutscience.eu | VAT IT10418650965 | Privacy policy | Cookie Policy
Registered office: Via Marco Ulpio Traiano 35/D - 20149 Milan (MI) - Italy | Operational office: Via Eritrea 21 – 20157 Milan (MI) - Italy

Linkedin

Platform and workflow OJS/PKP | Hosting Archimede Informatica | Customizations e-Danex Digital Solutions

More information about the publishing system, Platform and Workflow by OJS/PKP.